Manual of Clinical Oncology is a practical, accessible guide to the management of patients with cancer.
In an outline format designed for rapid reference, Manual of Clinical Oncology provides the essential information needed for fast, effective clinical decision-making at the bedside.
Coverage begins with principles of diagnosis and treatment and proceeds to specific malignancies and complications of cancer.
Manual of Clinical Oncology, Fifth Edition features a new chapter on bone marrow transplant and its complications and completely rewritten chapters on breast cancer and infectious complications of cancer.
Appendices cover chemotherapeutic regimens for lymphoma, complications of chemotherapy, tumor identifiers, and cytogenetic nomenclature.
Contents:
- Principles of Cancer Management
- Principles of Medical Oncology and Cancer Biology
- Nuclear Medicine
- Radiation Oncology
- Cancer Chemotherapeutic Agents
- Supportive Care
- Psychosocial Aspects of Cancer Care
- Solid Tumors
- Head and Neck Cancers
- Lung Cancer
- Gastrointestinal Tract Cancers
- Breast Cancer
- Gynecologic Cancers
- Testicular Cancer
- Urinary Tract Cancers
- Neurologic Tumors
- Endocrine Neoplasms
- Skin Cancers
- Sarcomas
- Cancers in Childhood
- Miscellaneous Neoplasms
- Metastases of Unknown Origin
- Hematologic Malignancies
- Hodgkin and Non-Hodgkin Lymphoma
- Plasma Cell Disorders
- Chronic Leukemias
- Myeloproliferative Disorders
- Acute Leukemia
- Specific Complications of Cancer
- Sexual Function and Pregnancy
- Metabolic Complications
- Cutaneous Complications
- Thoracic Complications
- Abdominal Complications
- Renal Complications
- Neuromuscular Complications
- Bone and Joint Complications
- Hematologic Complications
- Infectious Complications
- AIDS-Related Malignancies
Appendix A: Combination Chemotherapy Regimens for Hodgkin and Non-Hodgkin Lymphoma
- Combination regimens for Hodgkin Lymphoma
- Combination regimens for Non-Hodgkin Lymphoma
- Salvage regimens
Appendix B: Toxicity of Chemotherapy
- Toxicities and dosage modifications for antineoplastic agents
- NCI Common Toxicity Criteria
Appendix C: Tumor Identifiers
- Microscopic clues for tumor origin
- Immunohistochemical tumor markers
- Expected immunophenotypes on biopsies
Index